| Literature DB >> 34917853 |
S Chida1, M Sakamoto1, T Takino1,2, S Kawamoto1, K Hagiwara1.
Abstract
High-yield dairy cows need high energy feed during periods of increased milk production. The transitional feeding to high energy feed increases the risk of developing a variety of metabolic disorders. Here, five Holstein cows were fed a four-stage feeding protocol (3 weeks for each stage) ranging from 54.9 to 73.7% total digestive nutrients (TDN). The purpose of the study was to investigate the effect of lactic acid bacteria on high-energy-fed cows associated with transitional feeding, and to evaluate the effects of probiotics on intestinal bacterial changes and inflammatory responses. Three feed transition periods were established for five cows, and Lactobacillus plantarum RGU-LP1 (LP1) was fed as a probiotic during the high-energy feeding period. The number of lymphocyte subsets such as CD3-, CD4-, and CD8 positive cells decreased in response to the high energy feed. Lipopolysaccharide (LPS)-induced cytokine (IL-1β and IL-2) gene expression in peripheral blood mononuclear cells (PBMCs) was shown to increase in those animals receiving the high energy feed. However, supplementation with LP1 resulted in an increase in the number of lymphocyte subsets and the expression of IL-1β and IL-2 were returned to the level at low energy diet. These results suggest that high energy diets induce inflammatory cytokine responses following LPS stimulation, and that the addition of LP1 mitigates these results by regulating the LPS-induced inflammatory reaction. Therefore, the functional lactic acid bacteria LP1 is expected to regulate inflammation resulting from high energy feeding, and this probiotic could be applied to support inflammatory regulation in high-yield dairy cows.Entities:
Keywords: Anti-inflammatories; CD, cluster of differentiation; Dairy cows; EDTA, ethylenediaminetetraacetic acid; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; High-energy feed; IL, Interleukin; LPS, Lipopolysaccharide; Lactobacillus plantarum; PBMC, peripheral blood mononuclear cell; Probiotics; TDN, Total-Digestible-Nutrients; TGF, Transforming Growth Factor; TMR, Total-Mixed-Ration; TNF, Tumor Necrosis Factor
Year: 2021 PMID: 34917853 PMCID: PMC8666551 DOI: 10.1016/j.vas.2021.100222
Source DB: PubMed Journal: Vet Anim Sci ISSN: 2451-943X
Fig. 1Experimental design of transitional feeding protocol. Examined five cows are fed with each stage feed composition for 3 weeks (show TDN% in the frame). In stage 4, L plantarum (Lp1) was administered to all 5 cows under the same feed as stage 3. The arrow indicates the sampling point.
Diet composition at different the stages.
| Timothy Hay (%) | Concentrate (%) | ||||
|---|---|---|---|---|---|
| Alfalfa | Steam-flaked corn | DDGS | calcium carbonate for feed | ||
| Stage 1 (54.9%) | 100 | 0 | 0 | 0 | 0 |
| Stage 2 (68.1%) | 53.48 | 24.06 | 21.39 | 0 | 1.07 |
| Stage 3 (73.7%) | 35.12 | 30.09 | 22.73 | 10.33 | 0.83 |
*DDGS: Dried Distiller's Grains with Solubles (%): Total digestible nutrients (TDN).
Fig. 2Abundance of Bifidobacterium, Lactobacillus, and coliforms in rectal feces samples at each stage. Changes in the number of bacteria in the feces from feed stages 1 – 4 (Lp1 administration). Significant differences between groups are indicated by * p < 0.05.
Fig. 3Fluctuations in lumen pH due to feed changes
The average pH was measured at 3 times per day: before morning feeding, 5 h after feeding, and 10 h after feeding. The figure shows the mean and standard deviation of the five animals measured at each stage. a significant difference was confirmed between stages 2 and 3 with respect to stage 1 (* p < 0.05).
Fig. 4Comparison of the effects of specific dietary changes on various lymphocyte subsets.
The proportion of each of the lymphocyte subsets (CD3, CD4, CD8, and WC1) in each feed group is shown. A compares the changes in each lymphocyte positive rate in each stage (1–3). B shows the change in these populations between feed stages 3 and 4 (Lp1 administration). Significant differences between groups are indicated by * p < 0.05.
Relative expression of various cytokines in PBMCs.
| Stage 1 | Stage 2 | Stage 3 | Stage 4 | |
|---|---|---|---|---|
| 1.4 ± 1.1 | 1.1 ± 0.9 | 0.7 ± 0.2 | 0.6 ± 0.5 | |
| 1.8 ± 0.6 | 3.3 ± 1.3 | 8.0 ± 1.6 | 4.3 ± 2.2 | |
| 0.8 ± 0.3 | 1.5 ± 0.2 | 1.2 ± 0.3 | 1.2 ± 0.5 | |
| 1.1 ± 0.5 | 0.8 ± 0.4 | 2.6 ± 0.6 | 0.9 ± 0.5 | |
| 0.6 ± 0.3 | 0.8 ± 0.5 | 1.5 ± 0.6 | 0.4 ± 0.2 | |
| 1.3 ± 0.5 | 1.8 ± 0.9 | 2.0 ± 0.9 | 1.4 ± 0.5 |
p < 0.05, Significant differences in cytokine expression between stage 2 and 3.
p < 0.05, Significant differences in cytokine expression between stage 3 and 4.